Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial

There is no fulltext present in this item.

Title:	Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial
Author(s):	Smits, P.C.; Chang, Chun Chin; Chevalier, B.; West, N.; Gori, T.; Barbato, Emanuele; Onuma, Yoshinobu; Geuns, R.J.M. van
Publication year:	2020
Source:	Eurointervention, vol. 16, iss. 8, (2020), pp. 645-653
ISSN:	1774-024X
DOI:	https://doi.org/10.4244/EIJ-D-19-01079
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/227491
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Organization:	Cardiology
Journal title:	Eurointervention
Volume:	vol. 16
Issue:	iss. 8
Page start:	p. 645
Page end:	p. 653